Mandos Health Media Release | September 10, 2024

Read Mandos Health's Media Release Here

Read the letter from Mandos Health here:

Mandos-Health-Update-09.10.2024.pdf

Download PDF • 117KB

Here is a summary of the article:

• INPDA 2023 Meeting: Mandos attended the 2023 INPDA meeting in Tarragona, Spain, highlighting progress in the NPC community and supporting adrabetadex (VTS-270) research.

• Upcoming Conferences: Mandos will sponsor the 2024 Parseghian Fund Annual Conference and the NNPDF Family Support & Medical Conference.

• Research and Development: the FDA has accepted Mandos' request for a Type C Meeting scheduled in October to discuss the direction of the adrabetadex program’s development.

• Expanded Access Program: the EAP age criteria have been expanded to include patients from 3 months to 25 years old

---

To join our fight, as well as fund vital research for a cure, support the Australian NPC Disease Foundation in its goals of "Research. Cure. Persevere."

Ways to support NP-C in Australia:

• Donate online

• Check out upcoming events

• Shop at our online NPC store

• Fundraise your way! Check our free resources and inspo online.